Breast cancer predisposing alleles in Poland
- 1 July 2005
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 92 (1) , 19-24
- https://doi.org/10.1007/s10549-005-1409-1
Abstract
Mutant alleles of several genes in the DNA repair pathway have been found to predispose women to breast cancer. From a public health perspective, the importance of a given allele in a population is determined by the frequency of the allele and by the relative risk of breast cancer that it confers. In Poland founder alleles of the BRCA1, CHEK2 and NBS1 genes have been associated with an increased risk of breast cancer, but the relative contribution of each of these alleles to the overall breast cancer burden has not yet been determined. We screened 2012 unselected cases of breast cancer and 4000 population controls for 7 different mutations in these genes. Overall, a mutation was found in 12% of the cases and in 6% of the controls. Mutations in BRCA1 and CHEK2 contributed in approximately equal measure to the burden of breast cancer in Poland. A BRCA1 mutation was present in 3% of the cases. The missense BRCA1 mutation C61G was associated with a higher odds ratio for breast cancer (OR=15) than were either of the truncating BRCA1 mutations 4153delA (OR=2.0) and 5382insC (OR=6.2). In contrast, a higher odds ratio was seen for truncating CHEK2 mutations (OR=2.1) than for the missense mutation I157T (OR=1.4). This study suggests that cancer risks may be specific for particular alleles of a susceptibility gene and that these different risks should be taken into account by genetic counselors.Keywords
This publication has 9 references indexed in Scilit:
- A Novel Founder CHEK2 Mutation is Associated with Increased Prostate Cancer RiskCancer Research, 2004
- A high proportion of founder BRCA1 mutations in Polish breast cancer familiesInternational Journal of Cancer, 2004
- NBS1 Is a Prostate Cancer Susceptibility GeneCancer Research, 2004
- Hereditary ovarian cancer in PolandInternational Journal of Cancer, 2003
- Germline 657del5 mutation in the NBS1 gene in breast cancer patientsInternational Journal of Cancer, 2003
- Frequency of CHEK2*1100delC in New York breast cancer cases and controlsBMC Medical Genetics, 2003
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerAmerican Journal of Human Genetics, 2000
- BRCA1 mutations in young women with breast cancerThe Lancet, 1996